DE602004027839D1 - Verfahren zur vorhersage von anomalien des lipidmetabolismus - Google Patents

Verfahren zur vorhersage von anomalien des lipidmetabolismus

Info

Publication number
DE602004027839D1
DE602004027839D1 DE602004027839T DE602004027839T DE602004027839D1 DE 602004027839 D1 DE602004027839 D1 DE 602004027839D1 DE 602004027839 T DE602004027839 T DE 602004027839T DE 602004027839 T DE602004027839 T DE 602004027839T DE 602004027839 D1 DE602004027839 D1 DE 602004027839D1
Authority
DE
Germany
Prior art keywords
compound
lipidosis
phenylacetylglycine
phenylacetylglutamine
phenylalanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027839T
Other languages
English (en)
Inventor
Akira Horinouchi
Ikuo Mori
Mika Murabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of DE602004027839D1 publication Critical patent/DE602004027839D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
DE602004027839T 2003-12-26 2004-12-24 Verfahren zur vorhersage von anomalien des lipidmetabolismus Active DE602004027839D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003434151 2003-12-26
JP2004168849 2004-06-07
PCT/JP2004/019758 WO2005064344A1 (ja) 2003-12-26 2004-12-24 脂質代謝異常症の予測方法

Publications (1)

Publication Number Publication Date
DE602004027839D1 true DE602004027839D1 (de) 2010-08-05

Family

ID=34742146

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027839T Active DE602004027839D1 (de) 2003-12-26 2004-12-24 Verfahren zur vorhersage von anomalien des lipidmetabolismus

Country Status (6)

Country Link
US (1) US7399638B2 (de)
EP (1) EP1710585B1 (de)
JP (1) JP4555779B2 (de)
AT (1) ATE472102T1 (de)
DE (1) DE602004027839D1 (de)
WO (1) WO2005064344A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615892C (en) * 2005-07-25 2018-06-12 Basf Aktiengesellschaft A method for providing and analyzing an animal population having an essentially identical metabolome
JP5005955B2 (ja) * 2006-05-24 2012-08-22 田辺三菱製薬株式会社 被験物質の脂質代謝異常症誘発可能性を予測する方法
CA2667063A1 (en) * 2006-10-09 2008-04-17 F. Hoffmann-La Roche Ag Biomarker for mitochondrial toxicity associated with phospholipidosis
FI119745B (fi) 2006-12-05 2009-02-27 Paavo Kinnunen Menetelmä aineen fosfolipidoosia aiheuttavien ominaisuuksien ennustamiseksi
WO2009026153A1 (en) * 2007-08-17 2009-02-26 Metabolon, Inc. Biomarkers for alzheimer's disease and methods using the same
JP5051617B2 (ja) * 2007-12-17 2012-10-17 富士電機株式会社 遠心分離方法及び遠心分離装置
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
AU2015259294A1 (en) * 2014-05-12 2016-12-01 Quest Diagnostics Investments Llc Quantitation of tamoxifen and metabolites thereof by mass spectrometry
JP6051257B2 (ja) * 2015-04-15 2016-12-27 ライオン株式会社 脂質異常症への罹患しやすさを試験する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100807A (en) 1987-10-19 1992-03-31 Abbott Laboratories Phenylacetylglutamine (pag) analytical test
JPH07104351B2 (ja) * 1988-09-29 1995-11-13 株式会社日本抗体研究所 脂質代謝異常検出用キット
JPH11343300A (ja) 1998-03-13 1999-12-14 Tetsuro Fujita 新規ハプテン、それを認識する抗体およびそれらを用いた免疫学的測定法
AU772548B2 (en) * 1998-12-22 2004-04-29 Daiichi Pure Chemicals Co., Ltd. Monoclonal antibody against apolipoprotein A-I
US6306603B1 (en) * 1999-01-08 2001-10-23 Wakunaga Phaemaceutical Co., Ltd. CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism and diagnostic kits therefor
JP2001149082A (ja) * 1999-01-08 2001-06-05 Wakunaga Pharmaceut Co Ltd Ｃｄ３６変異遺伝子並びに脂質代謝異常により引き起こされる疾患の判定法および診断キット
JP2001066314A (ja) * 1999-06-23 2001-03-16 E Miller Norman 脂質代謝異常の検出方法及びこれを用いる疾病の検出方法

Also Published As

Publication number Publication date
EP1710585B1 (de) 2010-06-23
US20070166829A1 (en) 2007-07-19
US7399638B2 (en) 2008-07-15
EP1710585A4 (de) 2008-02-20
EP1710585A1 (de) 2006-10-11
WO2005064344A1 (ja) 2005-07-14
JP4555779B2 (ja) 2010-10-06
JPWO2005064344A1 (ja) 2007-07-19
ATE472102T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
Tomat et al. Imaging mobile zinc in biology
Petriz et al. Metaproteomics as a complementary approach to gut microbiota in health and disease
Yin et al. Preparation of a cyanine-based fluorescent probe for highly selective detection of glutathione and its use in living cells and tissues of mice
Wang et al. Gut microbiota and relevant metabolites analysis in alcohol dependent mice
Gailus-Durner* et al. Systemic first-line phenotyping
IL185021A0 (en) Diagnosis method of hepatic steatosis using biochemical markers
WO2008133729A3 (en) Sequential analysis of biological samples with intermediate bleaching of fluorescence detector
PT2073008E (pt) Métodos de imunoensaio melhorados
ATE420204T1 (de) Verfahren zur detektion von erkrankungen
DE602004027839D1 (de) Verfahren zur vorhersage von anomalien des lipidmetabolismus
JP2016533735A (ja) アルブミンの偽エステラーゼ加水分解反応に基づく特異的蛍光プローブおよび応用
CN101460851B (zh) 与二肽基肽酶有关的疾病状态的诊断和预后
ATE350659T1 (de) Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens
KR101872155B1 (ko) 시스테인 검출용 이광자 형광 프로브 화합물
Ruiz-Hernández et al. Trace element and lipidomic analysis of bottlenose dolphin blubber from the Yucatan coast: Lipid composition relationships
DE69815394D1 (de) Verfahren zur untersuchung von nierenkrankheiten
AR058510A1 (es) Procedimiento de diagnostico de enfermedades hepaticas y de muestreo de moleculas para el tratamiento de estas enfermedades
CN110372738A (zh) 一种定位脂滴检测硫化氢的荧光探针及其制备方法和应用
DE60133997D1 (de) Verfahren zum vorhersagen von preeclampsia und anderen krankheiten
JP6017724B1 (ja) 十二指腸液試料の膵液由来成分検出用試料としての適性評価方法
BR0111975A (pt) Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator
Wragg et al. Synaptic activity regulates the abundance and binding of complexin
JP2018145111A (ja) 生体分子検出用蛍光物質
Goicoechea et al. GST-Perfringolysin O production for the localization and quantification of membrane cholesterol in human and mouse brain and liver
Tan et al. Detection of biothiols in cells by a terbium chelate-Hg (II) system